Table 1.
Overall survival for stage IV patients according to first metastatic site
Time | BRA | DYG | PUL | LYM+SC |
3 months | 40.7% | 87.5% | 77.8% | 100% |
6 months | 18.5% | 35.0% | 64.8% | 80% |
9 months | 9.9% | 17.5% | 64.8% | 73.3% |
1 year | 0% | 0% | 64.8% | 66.0% |
2 years | 0% | 0% | 21.6% | 25.7% |
BRA – brain metastasis; DYG – liver and gastrointestinal tract metastasis; PUL – lung metastasis; LYM+SC - extra-regional lymph nodes and subcutaneous metastasis |